BACK: IMAC Corp Kapitalizatsiyaning daromadga nisbati

IMAC Regeneration Centers (BACK) kompaniyasining korporativ logotipi

Keng qamrovli jarrohliksiz bo'g'imlarni davolash usuli mijozlar sodiqligini mustahkamlaydi, bu esa tarixiy P/S koeffitsiyentiga ijobiy ta'sir ko'rsatadi. Fizioterapiyaga bo'lgan barqaror talab va davlat sug'urtasi doimiy pul oqimini kafolatlaydi, sarf materiallarining mahalliy xaridlari esa logistik uzilishlarni yumshatadi. 9.80 ning joriy qiymati ushbu metrikaning darajasini ko'rsatib, IMAC Holdings, Inc. (BACK) daromadlarining aksiyalar narxiga nisbatan bozor bahosini aks ettiradi.

BACK: imacholdings.comm P/S multiplikatori 21.02.2024 - 05.04.2025

IMAC Regeneration Centers (BACK) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Aksiya narxi imacholdings.comm|BACK - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi haqida ma'lumot:
Bozor bahosi IMAC Regeneration Centers|BACK - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Aksiyaning buxgalteriya qiymati IMAC Holdings|BACK - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor qiymati imacholdings.comm|BACK - Kompaniyaning jami aktivlari
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning kapitalga nisbati IMAC Holdings, Inc.|BACK - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati IMAC Corp|BACK - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati IMAC Regeneration Centers|BACK - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi IMAC Holdings|Shoshilinch likvidlik koeffitsiyenti imacholdings.comm
- foyda va qiymat multiplikatorlari haqida ma'lumot:
BACK - Sof foyda|Prognoz qilingan sof foyda IMAC Holdings, Inc.|BACK - Narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati IMAC Holdings Inc|BACK - Narx-foyda va o‘sish multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati IMAC Regeneration Centers|BACK - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda IMAC Holdings|BACK - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi imacholdings.comm|BACK - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi IMAC Holdings, Inc.
- emitentning tushumi va sotuvlari tafsilotlari:
BACK - Kompaniya savdosi|Kompaniyaning kelajakdagi savdosi imacholdings.comm|BACK - P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati IMAC Regeneration Centers
Kompaniyaning umumiy tahlili:imacholdings.comm (BACK)
IMAC Corp seriyali mahsuloti

P/S ko'rsatkichi aktivning haddan tashqari qimmat baholanganligini aniqlash uchun umumiy bozor kapitalizatsiyasini savdo hajmi bilan bog'lagan holda, daromadning bitta birligining bozor qiymatini belgilaydi. Kapitalizatsiyaning daromadga nisbatini tahlil qilish orqali investor IMAC Holdings, Inc. (BACK) kompaniyasining AQSh regenerativ tibbiyot sektori doirasidagi kengayish samaradorligini baholashi mumkin, bu yerda ambulator markazlar tarmog'ining kengayish sur'atlari bemorlar oqimining haqiqiy o'sishi orqali yuqori bozor bahosini tasdiqlashi lozim.

Raqobatdosh kompaniyalar

P/S multiplikatori hcahealthcare.com (HCA)|P/S multiplikatori THC (Tenet Healthcare Corporation)|FMS - Kapitalizatsiyaning daromadga nisbati|SOLV: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati EHC (Encompass)|UHS: P/S multiplikatori|davita.com - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati RadNet|Sotuvga nisbatan narx Option Care OPCH|Narxning daromadga nisbati Surgery Partners Corp (SGRY)|Narxning daromadga nisbati PINC (Premier Health)|P/S multiplikatori EYE (National Vision Holdings)|PGNY: Kapitalizatsiya va daromad nisbati|Ardent Health Partners - P/S multiplikatori|Narx/daromad koeffitsiyenti Select Medical Corporation SEM|Apollo Medical Holdings (ASTH) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati MD|USPH (US Physical Therapy) - P/S multiplikatori|PNTG - Narx/daromad multiplikatori|Narxning daromadga nisbati Organogenesis (ORGO)|Narx/daromad koeffitsiyenti Nutex Health Inc|Auna Health - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati SBC|Evolus, Inc. - P/S multiplikatori|Narx/daromad koeffitsiyenti chs.net CYH|beautyhealth.com (SKIN) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati MDWD|BTMD (Biote Corp) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati The Joint (JYNT)|Kapitalizatsiyaning daromadga nisbati DCGO (DocGo Inc.)|Narx/daromad koeffitsiyenti p3hp.org|P/S multiplikatori GANX (Gain Therapeutics)|EUDA Health Holdings - Narxning daromadga nisbati|Basel Medical Group Limited - P/S multiplikatori|CLGN - P/S multiplikatori|CUPR: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati concordmedical.com|Narxning daromadga nisbati American Shared Hospital Services|P/S multiplikatori MEDIROM Healthcare Group Inc.|Kapitalizatsiyaning daromadga nisbati ALBT (Avalon GloboCare)|Kapitalizatsiyaning sotish hajmiga nisbati DHAI|Narxning daromadga nisbati Longevity Health Holdings XAGE|Bozor kapitallashuvining daromadga nisbati NIVF|ATI Physical Therapy Corp - P/S multiplikatori|Sotuvga nisbatan narx CareMax Inc.|KDLY: P/S multiplikatori|ModivCare Corp (MODV) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati NVOS|SSY (SunLink Health Systems, Inc) - Kapitalizatsiyaning sotish hajmiga nisbati